Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$166.59
+0.16%
Mkt Cap $16.71B
Analyst Ratings
Buy
35
Hold
3
Sell
0
Price Target (69 analysts)
$188.62
Range $140.00 – $230.00
Implied Upside
+13.2%
Consensus $188.62 vs current $166.59